ICUD-EAU International Consultation on Kidney Cancer 2010: Treatment of Metastatic Disease

Patard J., Pignot G., Escudier B., Eisen T., Bex A., Sternberg C., ...Daha Fazla

EUROPEAN UROLOGY, cilt.60, sa.4, ss.684-690, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 60 Sayı: 4
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1016/j.eururo.2011.06.017
  • Dergi Adı: EUROPEAN UROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.684-690
  • Anahtar Kelimeler: Renal cell carcinoma, First-line, Second-line, Treatment algorithms, VEGF-targeted therapy, mTOR inhibitors, RENAL-CELL CARCINOMA, SORAFENIB PLUS INTERFERON-ALPHA-2B, COMBINATION TARGETED THERAPY, PHASE-II TRIAL, PULMONARY RESECTION, BEVACIZUMAB, SUNITINIB, ALPHA, NEPHRECTOMY, EVEROLIMUS
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Context: Until the development of novel targeted agents directed against angiogenesis and tumour growth, few treatment options have been available for the treatment of metastatic renal-cell carcinoma (mRCC).